SJ Wort

1.1k total citations · 1 hit paper
31 papers, 680 citations indexed

About

SJ Wort is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, SJ Wort has authored 31 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in SJ Wort's work include Pulmonary Hypertension Research and Treatments (18 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). SJ Wort is often cited by papers focused on Pulmonary Hypertension Research and Treatments (18 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). SJ Wort collaborates with scholars based in United Kingdom, Australia and France. SJ Wort's co-authors include Michael Α. Gatzoulis, Konstantinos Dimopoulos, Joanna Pepke‐Żaba, James Lordan, Andrew J. Peacock, Paul A. Corris, Andrew J. Fisher, Martin Johnson, Robin Condliffe and J. Simon R. Gibbs and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Heart Journal and European Respiratory Journal.

In The Last Decade

SJ Wort

28 papers receiving 670 citations

Hit Papers

Changing Demographics, Epidemiology, and Survival of Inci... 2012 2026 2016 2021 2012 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SJ Wort United Kingdom 6 615 355 120 117 71 31 680
Abby Poms United States 7 585 1.0× 374 1.1× 100 0.8× 54 0.5× 52 0.7× 12 610
Volker Westerkamp Germany 6 511 0.8× 352 1.0× 87 0.7× 41 0.4× 46 0.6× 9 570
DG Kiely United Kingdom 5 490 0.8× 344 1.0× 79 0.7× 59 0.5× 26 0.4× 19 560
David Boulate France 16 522 0.8× 368 1.0× 80 0.7× 89 0.8× 42 0.6× 52 682
LJ Rubin United States 2 626 1.0× 436 1.2× 122 1.0× 66 0.6× 33 0.5× 6 653
Roela Sadushi‐Kolici Austria 14 512 0.8× 409 1.2× 129 1.1× 46 0.4× 29 0.4× 28 606
Kathy Feldkircher United States 5 1.2k 2.0× 774 2.2× 288 2.4× 117 1.0× 60 0.8× 8 1.3k
Johannes M. Douwes Netherlands 15 719 1.2× 489 1.4× 142 1.2× 293 2.5× 63 0.9× 37 777
Abby Krichman United States 7 1.3k 2.2× 867 2.4× 308 2.6× 119 1.0× 61 0.9× 15 1.4k
Melanie Nies United States 11 288 0.5× 131 0.4× 38 0.3× 82 0.7× 53 0.7× 29 364

Countries citing papers authored by SJ Wort

Since Specialization
Citations

This map shows the geographic impact of SJ Wort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Wort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Wort more than expected).

Fields of papers citing papers by SJ Wort

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Wort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Wort. The network helps show where SJ Wort may publish in the future.

Co-authorship network of co-authors of SJ Wort

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Wort. A scholar is included among the top collaborators of SJ Wort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Wort. SJ Wort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Price, Laura, Ifan Jenkin, Konstantinos Dimopoulos, et al.. (2025). Survival in Patients With Pulmonary Hypertension Associated With Fibrotic Interstitial Lung Disease is Independent of ILD Subtype: A London Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3281–A3281.
2.
Mumby, Sharon, Frédéric Perros, Alberto Papi, et al.. (2023). Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1. Respiratory Research. 24(1). 193–193. 6 indexed citations
3.
Dawes, Timothy J. W., Konstantinos Dimopoulos, Colm McCabe, et al.. (2021). Survival effects of pulmonary vasodilators in group 3 pulmonary hypertension. OA177–OA177. 1 indexed citations
4.
Mumby, Sharon, Frédéric Perros, C Hui, et al.. (2021). Extracellular matrix degradation pathways and fatty acid metabolism regulate distinct pulmonary vascular cell types in pulmonary arterial hypertension. Pulmonary Circulation. 11(1). 1–16. 9 indexed citations
6.
Price, Laura, Colm McCabe, Geoff J.M. Parker, et al.. (2020). Dynamic oxygen-enhanced magnetic resonance imaging-based quantification of pulmonary hypertension. 853–853. 1 indexed citations
7.
Wort, SJ, et al.. (2019). Cell freehaemoglobin and pulmonary artery endothelial cell dysfunction. Spiral (Imperial College London). PA5042–PA5042. 1 indexed citations
8.
Mumby, Sharon, Natalia Gambaryan, Chao Meng, et al.. (2016). Bromodomain and extra‐terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension. Respirology. 22(1). 157–164. 40 indexed citations
9.
Keir, Gregory J., Arjun Nair, Stamatia Giannarou, et al.. (2015). Pulmonary Vasospasm in Systemic Sclerosis: Noninvasive Techniques for Detection. Pulmonary Circulation. 5(3). 498–505. 2 indexed citations
10.
Garfield, Benjamin, Lisa Parfitt, Carl Harries, et al.. (2014). S144 Quality Of Life In Idiopathic Pulmonary Arterial Hypertension Is Associated With Quadriceps Function And Size. Thorax. 69(Suppl 2). A76–A77. 1 indexed citations
11.
Ramakrishnan, Latha, et al.. (2014). P18 Robo1/4-slit2 Expression In Pulmonary Vascular Cells: Implications For Pah?. Thorax. 69(Suppl 2). A85–A85.
12.
Keir, Gregory J., Tamera J. Corte, Lisa Parfitt, et al.. (2013). Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia: A randomized, double-blind, placebo-controlled study. European Respiratory Journal. 42(Suppl 57). 1779–1779. 3 indexed citations
13.
Dimopoulos, Konstantinos, SJ Wort, & Michael Α. Gatzoulis. (2013). Pulmonary hypertension related to congenital heart disease: a call for action. European Heart Journal. 35(11). 691–700. 113 indexed citations
15.
Ling, Yi, Martin Johnson, David G. Kiely, et al.. (2012). Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension: Results from the Pulmonary Hypertension Registry of the United Kingdom and Ireland. American Journal of Respiratory and Critical Care Medicine. 186(8). 790–796. 392 indexed citations breakdown →
16.
Cordingley, Jeremy, et al.. (2009). Extracorporeal carbon dioxide removal to "protect" the lung. Thorax. 64(8). 726–727. 3 indexed citations
17.
Corte, Tamera J., SJ Wort, Michael Α. Gatzoulis, et al.. (2009). Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax. 64(10). 883–888. 83 indexed citations
20.
Wort, SJ, Jane A. Mitchell, & Timothy W. Evans. (2001). Inducible nitric oxide synthase: a tissue-specific affair?. American Journal of Physiology-Lung Cellular and Molecular Physiology. 280(3). L387–L389. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026